When a COVID-19 Vaccine is available, most of the world will have access to it thanks to a unique platform for international cooperation called The COVAX Facility.
The COVAX Facility is a platform for pooled investments in the development, manufacture and distribution of a COVID-19 vaccine. At time of recording, 172 countries have entered into an initial agreement with COVAX, representing about 70% of the world’s population. The goal of the COVAX Facility is to provide 2 billion doses of a vaccine to cover 20% of the population of all participating countries by the end of 2021.
GAVI–The Vaccine Alliance administers COVAX and on the line with me today to explain how COVAX works is the Managing Director for Country Programs at GAVI Thabani Maphosa
This episode is part two of a series examining how the COVID-19 pandemic has given rise to new forms of international cooperation to accelerate the end of the pandemic. Part one, released last week is my interview with the CEO of the Coalition for Pandemic Preparedness Innovations, CEPI, which has made early and ongoing investments in the development and manufacture of the vaccines.
Episode 160: Wendy Pearlman is an academic who studies the Middle East in an unusual way
How to Build Peace in a Region Once Beset by al Shabaab
Episode 142: Jeremy Konyndyk
The Coup in Tunisia
